We are live on ! Find out more
RIGL icon

Rigel Pharmaceuticals
RIGL

138 hedge funds and large institutions have $334M invested in Rigel Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 36 increasing their positions, 50 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

26% more capital invested

Capital invested by funds: $265M → $334M (+$68.7M)

16% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 19

2% more funds holding

Funds holding: 135 → 138 (+3)

0.32% less ownership

Funds ownership: 8.6% → 8.27% (-0.32%)

28% less repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 50

42% less call options, than puts

Call options by funds: $980K | Put options by funds: $1.69M

Holders
138
Holders Change
+3
Holders Change %
+2.22%
% of All Funds
2.78%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
22
Increased
36
Reduced
50
Closed
19
Calls
$980K
Puts
$1.69M
Net Calls
-$712K
Net Calls Change
-$707K

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$16.1M
2
Citadel Advisors
Citadel Advisors
Florida
+$4.11M
3
Morgan Stanley
Morgan Stanley
New York
+$3.76M
4
SGA
Sector Gamma AS
Norway
+$3.35M
5
RG
Redmile Group
California
+$1.83M

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$5.98M
2
NMC
NEA Management Company
Maryland
-$5.93M
3
PAI
Palo Alto Investors
California
-$5.79M
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$4.67M
5
CS
Candriam SCA
Luxembourg
-$4.08M
Name Holding Trade Value Shares
Change 		Change in
Stake
Russell Investments Group
26
Russell Investments Group
United Kingdom
$2.23M +$742K +30,200 +48%
JGC
27
J. Goldman & Co
New York
$2.02M -$453K -18,456 -18%
N
28
Nuveen
North Carolina
$1.87M +$43.3K +1,765 +2%
RG
29
Redmile Group
California
$1.79M +$1.83M +74,458 New
IC
30
Ikarian Capital
Texas
$1.67M -$2.42M -98,500 -59%
Bank of New York Mellon
31
Bank of New York Mellon
New York
$1.62M -$27.9K -1,135 -2%
Assenagon Asset Management
32
Assenagon Asset Management
Luxembourg
$1.34M +$822K +33,473 +150%
Wells Fargo
33
Wells Fargo
California
$1.33M -$1.49M -60,849 -52%
WMSA
34
Weiss Multi-Strategy Advisers
New York
$1.19M -$12K -487 -1%
Charles Schwab
35
Charles Schwab
California
$961K -$40.5K -1,648 -4%
California Public Employees Retirement System
36
California Public Employees Retirement System
California
$922K +$20.6K +840 +2%
CS
37
Credit Suisse
Switzerland
$919K +$545K +22,180 +137%
Swiss National Bank
38
Swiss National Bank
Switzerland
$918K – – –
TI
39
Telemetry Investments
New York
$780K +$244K +9,950 +44%
AG
40
Artal Group
Luxembourg
$771K -$41.5K -1,690 -5%
Susquehanna International Group
41
Susquehanna International Group
Pennsylvania
$706K +$537K +21,879 +290%
CS
42
Candriam SCA
Luxembourg
$672K -$4.08M -166,300 -86%
Rafferty Asset Management
43
Rafferty Asset Management
New York
$650K +$665K +27,073 New
State of Wisconsin Investment Board
44
State of Wisconsin Investment Board
Wisconsin
$623K – – –
California State Teachers Retirement System (CalSTRS)
45
California State Teachers Retirement System (CalSTRS)
California
$613K +$2.95K +120 +0.5%
Bank of Montreal
46
Bank of Montreal
Ontario, Canada
$603K -$429K -17,492 -42%
TRCT
47
Tower Research Capital (TRC)
New York
$547K +$470K +19,158 +529%
Squarepoint
48
Squarepoint
New York
$537K -$350K -14,249 -39%
Principal Financial Group
49
Principal Financial Group
Iowa
$524K +$174K +7,097 +48%
AA
50
ALPS Advisors
Colorado
$517K -$35.7K -1,453 -6%
1
2
3 4 5

RIGL Hedge Fund Activity: Q3 2020 in Review

138 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Rigel Pharmaceuticals (RIGL) for Q3 2020, worth a combined $334M — up 26% from $265M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new RIGL positions and 19 closed out — a net gain of 3 holders — while 36 added to existing stakes and 50 trimmed.

The largest buyer was State Street, adding an estimated $16.1M. The largest seller was Renaissance Technologies, cutting an estimated $5.98M.

  • 138 institutional investors held Rigel Pharmaceuticals (RIGL) as of Q3 2020, up from 135 in Q2 2020.
  • Funds reported $334M of Rigel Pharmaceuticals stock for Q3 2020, up 26% quarter-over-quarter.
  • 22 funds opened new Rigel Pharmaceuticals positions in Q3 2020 and 19 closed out, a net change of +3 holders.
  • The largest Rigel Pharmaceuticals buyer in Q3 2020 was State Street, an estimated $16.1M added.
  • The largest Rigel Pharmaceuticals seller in Q3 2020 was Renaissance Technologies, an estimated $5.98M sold.

Based on aggregated 13F filings for Q3 2020.